Single Dose of Psilocybin Yields Long-Term Depression Remission in Over 50% of Cancer Patients
Research, Treatment
A single 25mg dose of psilocybin paired with psychological support has resulted in 57% of patients.
In this episode, David talks with Kimberly Carlson, CEO & CFO of Mushrooms Inc., a company that is aiming to bring forth a new era of sustainability with the use of mycelium.
In this episode, David talks with Kimberly Carlson, CEO & CFO of Mushrooms Inc., a company that is aiming to bring forth a new era of sustainability with the use of mycelium.
Mushrooms Inc., with the ticker symbol MSRM (OTC: MSRM), is the first in the US stock market to focus on the industrial aspect of mushrooms. The Company is contributing to the global effort towards regenerative agriculture with a special emphasis on the mushroom industry.
Mushrooms Inc.’s Research and Development is dedicated to promoting the use of mycology in manufacturing. This involves replacing harmful plastics and packaging with sustainable, biodegradable options, as well as enhancing the quality of medical textiles and fabrics.
Mycelium, which are made up of branching, thread-like hyphae, can be utilized to create a variety of environmentally-friendly products, such as bricks, packaging, textiles, and medical gauze. In this segment, David and Kimberly discuss Mushrooms Inc.’s objectives.
You can find out more information on Mushrooms Inc. here.
Leave a Reply
Want to join the discussion?Feel free to contribute!